Listen Now
Topics Covered
- Overview of Diffuse Large B-Cell Lymphoma, in the Context of COVID-19
- Staging & Grading
- Current Standard of Care
- Treatment Options for Resistant Disease
- Emerging Treatment Approaches
- Updates on Clinical Trials
- How Research Contributes to Treatment Options
- Tips to Manage Side Effects & Discomfort
- Key Questions to Ask Your Health Care Team
- Follow-Up Care: What to Expect
- Guidelines to Prepare for Telehealth/Telemedicine Appointments, including Technology & List of Questions
- Questions for Our Panel of Experts
Our Panel of Experts
Sarah C. Rutherford, MD
John P. Leonard, MD/Gwirtzman Family Research Scholar in Lymphoma, Assistant Professor of Medicine, Weill Cornell Medical College, Cornell University
Catherine S M Diefenbach, MD
Associate Professor of Medicine, Translational Director of Hematology, Director Clinical Lymphoma, Perlmutter Cancer Center, An NCI-Designated Comprehensive Cancer Center, NYU Langone Health
Adolfo Enrique Diaz, MD, MSc
Assistant Professor, Department of Medicine, Division of Hematology-Oncology, Mays Cancer Center, UT Health San Antonio MD Anderson Cancer Center
Belita Cowan, MA
President, Lymphoma Foundation of America
Carolyn Messner, DSW, BCD, FAPOS, FAOSW
Director of Education and Training, CancerCare
Brochure
You can download the brochure for this workshop
(112 KB)
Workshop Date
This workshop was originally recorded on May 12, 2021.